Cómo citar
1.
Opromolla DVA. A questão das 12 doses da poliquimioterapia para a hanseníase. Hansen. Int. [Internet]. 30 de noviembre de 1999 [citado 23 de noviembre de 2024];24(2):97-9. Disponible en: https://periodicos.saude.sp.gov.br/hansenologia/article/view/36422
Resumen
.
Citas
1. BRACKEL, Win H. Van Proposal regarding MDT. Leprosy Review, v.70, p.71-72, March, 1999. (Letters to the Editor).
2. INTERNATIONAL LEPROSY CONGRESS, 25, Beijing, 1998. Reports. Beijing, China: The International Leprosy Association, 1998.
3. JAMET, Pierre, JI Baohong. Releapse after- long up of multibacillary patients treated by WHO multidrug regimen. International Journal of Leprosy, v.63, no 2, p.195-201, June, 1995.
4. JI Baohong. Why multidrug therapy for multibacilalry leprosy can be shortned to 12 months. Leprosy Review, v.69, no ,2, p.106-109, March, 1998. (Editorial).
5. LYNCH, Patrick. Multdurg therapy. Leprosy Review, v.70, p.70-71, March, 1999. (Letters to the Editor).
6. McDOUGALL, A. Colin. Recent development in the chemotherapy of leprosy. Leprosy Review, v.68, no 4, p.294-298, December, 1997. (Editorial).
7. WATERS, M. Is it safe to shorten multidrug therapy for lepromatous (LL and BL) leprosy to 12 months. Leprosy Review, v.69, no ,2, p.110-111, March, 1998. (Commentary).
8. WHO Expert Commitee on Leprosy, Seventh report. WHO technical report Series, no 874. World Health Organization, Geneva 1998.
9. WHO Study Group. Chemoheapy of leprosy. WHO technical report Series, rig 847. World Health Organization, Geneva 1994.
2. INTERNATIONAL LEPROSY CONGRESS, 25, Beijing, 1998. Reports. Beijing, China: The International Leprosy Association, 1998.
3. JAMET, Pierre, JI Baohong. Releapse after- long up of multibacillary patients treated by WHO multidrug regimen. International Journal of Leprosy, v.63, no 2, p.195-201, June, 1995.
4. JI Baohong. Why multidrug therapy for multibacilalry leprosy can be shortned to 12 months. Leprosy Review, v.69, no ,2, p.106-109, March, 1998. (Editorial).
5. LYNCH, Patrick. Multdurg therapy. Leprosy Review, v.70, p.70-71, March, 1999. (Letters to the Editor).
6. McDOUGALL, A. Colin. Recent development in the chemotherapy of leprosy. Leprosy Review, v.68, no 4, p.294-298, December, 1997. (Editorial).
7. WATERS, M. Is it safe to shorten multidrug therapy for lepromatous (LL and BL) leprosy to 12 months. Leprosy Review, v.69, no ,2, p.110-111, March, 1998. (Commentary).
8. WHO Expert Commitee on Leprosy, Seventh report. WHO technical report Series, no 874. World Health Organization, Geneva 1998.
9. WHO Study Group. Chemoheapy of leprosy. WHO technical report Series, rig 847. World Health Organization, Geneva 1994.
Esta obra está bajo una licencia internacional Creative Commons Atribución 4.0.
Descargas
Los datos de descargas todavía no están disponibles.
